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Abstract
Complex diseases or phenotypes may involve multiple genetic variants and interactions between genetic, environmental
and other factors. Current genome-wide association studies (GWAS) mostly used single-locus analysis and had identified
genetic effects with multiple confirmations. Such confirmed single-nucleotide polymorphism (SNP) effects were likely to be
true genetic effects and ignoring this information in testing new effects of the same phenotype results in decreased
statistical power due to increased residual variance that has a component of the omitted effects. In this study, a multi-locus
association test (MLT) was proposed for GWAS analysis conditional on SNPs with confirmed effects to improve statistical
power. Analytical formulae for statistical power were derived and were verified by simulation for MLT accounting for
confirmed SNPs and for single-locus test (SLT) without accounting for confirmed SNPs. Statistical power of the two methods
was compared by case studies with simulated and the Framingham Heart Study (FHS) GWAS data. Results showed that the
MLT method had increased statistical power over SLT. In the GWAS case study on four cholesterol phenotypes and serum
metabolites, the MLT method improved statistical power by 5% to 38% depending on the number and effect sizes of the
conditional SNPs. For the analysis of HDL cholesterol (HDL-C) and total cholesterol (TC) of the FHS data, the MLT method
conditional on confirmed SNPs from GWAS catalog and NCBI had considerably more significant results than SLT.
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Introduction
Genome-wide association studies (GWAS) have identified
genetic variants associated with a number of complex diseases or
phenotypes [1], [2], [3] and some of these variants had
confirmations from several studies [1]. Published GWAS studies
typically used a single-locus test (SLT), in which each variant is
tested individually for association with a specific phenotype.
Single-locus analysis may not be the best approach in the presence
of confirmed SNP effects, because confirmed effects become a
component of random residuals and decrease statistical power for
detecting new effects if those true effects are omitted in the
analysis. Controlling genetic backgrounds in single-marker tests
was well explored in the area of QTL mapping including Zeng’s
CIM [4] and Jansen’s multiple regression method [5]. Roeder et al
[6] proposed to use linkage genome scan results in GWAS to
achieve higher power. In a recent meta-analysis on smoking
behavior, a novel SNP was identified with genome-wide
significance related to smoking conditional on a known SNP [7].
Conditional analysis was also used in other meta-analysis in
GWAS [8]. In this study, we propose a multi-locus test (MLT) that
tests each candidate SNP conditional on confirmed SNPs for
GWAS analysis to increase the statistical power for detecting new
SNP effects, and we demonstrate the MLT method had increased
statistical power relative to SLT using analytical formulae derived
in this study and using simulation, case studies, and the
Framingham Heart Study (FHS) data.
Methods
Predicted Statistical Power of MLT and SLT
The multiple linear regression model for the MLT method can
be expressed as:
Yi~mzFibZzGibGzGi,sbszei ð1Þ
where m=the population mean of the phenotypic values, Zi=1 6p
vector of the p covariates for subject i (i=1,…,N) to account for
environment, population stratification, and other factors; bZ=p61
vector of the partial regression coefficients of the covariates Zi;
Gi=(Gi,1, Gi,2,… ,Gi,s21)=1 6(S21) vector of the S21 SNP
genotypes that were confirmed to be associated with the
phenotype for subject i, with Gi,j taking values of 0, 1 or 2
according to the number of copies of the minor allele for subject i
at SNP j; bG=(S21)61 vector of partial regression coefficients of
S21 conditional SNPs; Gi,s=the genotype value of the candidate
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and ei=random residual that is assumed to follow N(0, s
2) normal
distribution. The residual variance of Equation 1 is
s2
ei~var yiDGi,s,Gi,Zi ðÞ ~var ei ðÞ ~s2 ð2Þ
A standard t-test can be used for testing the significance of the
candidate SNP based on testing the following hypotheses, H0:
bs=0, where bs is the regression coefficient of the candidate SNP
and is the Mth element of b=(m, bZ, bG, bs) and M=1+p+S. One-
sided statistical power was derived in this study for simplicity (two-
sided t-test statistical power can be obtained similarly but is not
considered here). Using a multiple linear regression framework,
the power of the one-sided t-test can be formulated as:
PI~
ðz?
ta
ft ,l,N{M ðÞ dt ð3Þ
where ta denotes the a% quantile value for t distribution and f
denotes the non-central t-distribution with N2M degrees of
freedom and non-centrality parameter:
l~
^ b bs ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
var ^ b bs
   r ~
^ b bs ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
^ S SMM
p ð4Þ
where ^ S SMM =the element at the Mth row and Mth column of
variance-covariance matrix ^ S S, and ^ S S is a M6M variance-
covariance matrix of ^ b bs and can be estimated as:
^ S S~var ^ b b
  
~ X’X ðÞ
{1s2 ð5Þ
where X is the design matrix in Equation 1.
For SLT, the statistical model is the same as Equation 1 except
that the residual term is now a summation of confirmed effects and
random residuals. The residual variance for the SLT model is no
longer s
2 and has the following mathematical expression:
s2
ei~var yiDZi,Gi,s ðÞ ~var GibGzei ðÞ ~ b
T
Gvar Gi ðÞ bGzs2 ð6Þ
where var(Gi) is calculated based on the Gi values defined in
Equation 1. Equation 6 shows that the residual variance of the
SLT model is inflated over the MLT model of Equation 1 due to
the fact that confirmed SNP effects are now in the residual term of
Equation 6. Using this inflated estimated residual variance, the
variance of ^ b bs can be estimated by:
var ^ b bs
  
~cs2
ei ð7Þ
where c is the element at the (p+2)th row and (p+2)th column of
matrix X’X ðÞ
{1 and X is the design matrix for the regression
model of SLT. Therefore, the t-test statistic for SLT does not have
a t-distribution but a t-distribution divided by a constant
t~
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
cs2
ei
^ S SMM
s
.
Similar to Equations 3, the power of the one-sided t-test can be
formulated as:
PI~
ðz?
tta
ft ,l,N{p{2 ðÞ dt ð8Þ
where ta denotes the a% quantile value for t-distribution with
N2p22 degrees of freedom and f denotes the non-central t-
distribution with N2p22 degrees of freedom and non-central
parameter l.
Results and Discussion
Evaluation of Statistical Power of MLT and SLT Using
Simulation and Real Data
The analytical formulae for statistical power for MLT
accounting for confirmed effects and for SLT without accounting
for confirmed effects (Equation 3 and Equation 8) were validated
by simulated data of 2000 subjects for various effect sizes of the
candidate SNP and confirmed SNPs with 10,000 repeats. The
phenotypic values were simulated by the summation of a
population mean, three additive SNP effects and a random error
which followed a standard normal distribution. The three SNPs
were simulated under Hardy-Weinberg equilibrium and linkage
equilibrium with allele frequencies, 0.3, 0.4 and 0.2. The first two
SNPs were assumed to have confirmed effects and the last SNP
was assumed to be the candidate SNP. The candidate SNP was
tested by the MLT and SLT methods in each simulation.
Empirical power was calculated as the proportion of significant
results from all 10,000 simulation results. We fixed the effects of
the two confirmed SNPs as 0.3 and 0.2 standard deviation of
residuals (SD) and varied the effect of the candidate SNP from
0.04 to 0.2 SD. Simulated statistical power were nearly identical to
the predicted power for MLT and SLT based on different
candidate SNP effect sizes (Table S1) and on different population
sizes (Table S2). With this knowledge of the power formulae being
correct, predicted statistical power for MLT and SLT were
calculated for various effect sizes of the confirmed SNPs (Table 1).
Table 1. Power comparison between MLT (Power I) and SLT (Power II) with various conditional SNP effect sizes and constant effect
size of 0.1 SD for the candidate SNP.
Effect Size 0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9 1.0
Power I 0.713 0.713 0.713 0.713 0.713 0.713 0.713 0.713 0.713 0.713
Power II 0.710 0.701 0.686 0.665 0.638 0.606 0.568 0.525 0.479 0.429
Improvement 0.003 0.012 0.027 0.048 0.075 0.108 0.146 0.188 0.235 0.284
doi:10.1371/journal.pone.0015006.t001
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effect sizes for some confirmed SNP effects. We collected all
reported SNP effects for HDL cholesterol (HDL-C), LDL
cholesterol (LDL-C), triglycerides (TG), total cholesterol (TC),
and serum metabolites (SM) from the GWAS catalog [1]. The
effect sizes and risk allele frequencies of those SNPs were extracted
and utilized for the power calculations. After filtering out SNPs in
high linkage disequilibrium (LD) by only keeping one SNP with
the largest effect size in each high LD region, the final selection of
confirmed SNP markers included 22 relatively independent SNPs
with effect sizes of 0.07–0.24 SD for HDL-C, 24 SNPs with effect
sizes of 0.07–0.35 SD for LDL-C, 13 SNPs with effect sizes of
0.06–0.42 SD for TG, and 19 SNPs with effect sizes of 0.06–0.24
SD for TC. For SM, we extracted five SNPs which explained 5.6
to 36.3 percent of the total phenotypic variation [1], [2].
Conditional on those known significant SNP effects, statistical
power of MLT increased over that of SLT by about 4–5% for
HDL-C, LDL-C, TG and TC. The pattern of the heatmap for
statistical power was similar for these four traits and the heatmap
for HDL-C is shown in Figure 1A. Largest improvements were in
the region where candidate SNPs had small effect sizes and large
allele frequencies or candidate SNPs had medium effect sizes and
relatively low allele frequencies (0.1–0.2). The increase in statistical
power of MLT over SLT was much larger for SM, varying from
10% to 30%, because of the large effect sizes of the known SNPs
(Figure 1B).
For GWAS analysis using real data, true statistical power is not
observable but MLT is expected to have more significant results
than SLT. To compare observed statistical significance of MLT
and SLT, we used the FHS GWAS data (version 2) that had 6575
individuals with SNP genotypes of the 500k SNP panel from
dbGAP [9]. Of the 6575 individuals, 6078 individuals had
observations on HDL-C and 6431 individuals had observations
on TC. From the 500k SNP panel, 432,096 SNP markers with
known locations and minor allele frequencies 0.01 or greater were
selected and tested. The original cholesterol measures deviated
from normality and had outliers. The Box-Cox transformation
analysis [10] implemented by the R package [11] showed that the
log-transformation was approximately the best transformation to
achieve normality for HDL-C and TC. Age, age-squared,
cholesterol treatment, blood sugar, body mass index, smoking
status, number of cigars smoked, alcohol consumption and sex
were adjusted for transformed HDL-C. Blood sugar, body mass
index, smoking status, and sex were adjusted for transformed TC.
The testing of SNP effects used the generalized least squares
version [12] of epiSNP [13]. From the GWAS catalog [1] and
NCBI (http://www.ncbi.nlm.nih.gov), we selected six SNP
markers (Table 2) with multiple confirmations. These six SNP
markers were independent of each other because pairwise
correlations measured by R-square among these SNPs were
nearly zero. Results showed that MLT had more significant results
than SLT for both HDL-C and TC (Table 2). The first two
markers in Table 2 had the largest improvement in observed
significance (reduced P-value), while the remaining markers only
had minor improvement.
In our analysis, we did not impute genotypic data to fill in
missing genotypes so that the MLT test had smaller sample size
than SLT. The observed significance should have been larger than
observed in Table 2 if the missing genotypes were filled by
genotype imputing using software like MACH [14] and BEAGLE
[15]. Although improvement in statistical significance could be
small in some cases, such improvement could be easily achieved
using GWAS analysis software like PLINK [16] and epiSNP [13]
that provide options to incorporate covariates. Due to incorpo-
rating confirmed effects, MLT has smaller degrees of freedom for
residuals and can be less robust than SLT. Fortunately, sample size
in typical GWAS studies (thousands) is large enough for
incorporating relatively small number of confirmed effects (tens).
Figure 1. Power improvement of the MLT method conditional on confirmed SNP effects over the SLT method. a, HDL Cholesterol. b,
Serum metabolities.
doi:10.1371/journal.pone.0015006.g001
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MLT is useful for identifying new genetic variants with smaller
effects.
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